NeuroMetrix (NURO) Competitors $4.06 +0.01 (+0.25%) As of 03:52 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends NURO vs. COCH, SURG, POCI, IRIX, DRIO, XAIR, PTHL, CODX, BSGM, and FEMYShould you be buying NeuroMetrix stock or one of its competitors? The main competitors of NeuroMetrix include Envoy Medical (COCH), SurgePays (SURG), Precision Optics (POCI), IRIDEX (IRIX), DarioHealth (DRIO), Beyond Air (XAIR), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), Co-Diagnostics (CODX), BioSig Technologies (BSGM), and Femasys (FEMY). These companies are all part of the "medical equipment" industry. NeuroMetrix vs. Envoy Medical SurgePays Precision Optics IRIDEX DarioHealth Beyond Air Pheton Holdings Ltd Class A Ordinary Shares Co-Diagnostics BioSig Technologies Femasys Envoy Medical (NASDAQ:COCH) and NeuroMetrix (NASDAQ:NURO) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, community ranking, valuation, analyst recommendations, institutional ownership, earnings and risk. Do institutionals & insiders hold more shares of COCH or NURO? 8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 19.4% of NeuroMetrix shares are held by institutional investors. 60.5% of Envoy Medical shares are held by company insiders. Comparatively, 4.4% of NeuroMetrix shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media favor COCH or NURO? In the previous week, NeuroMetrix had 2 more articles in the media than Envoy Medical. MarketBeat recorded 2 mentions for NeuroMetrix and 0 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.00 beat NeuroMetrix's score of 0.33 indicating that Envoy Medical is being referred to more favorably in the media. Company Overall Sentiment Envoy Medical Positive NeuroMetrix Neutral Is COCH or NURO more profitable? NeuroMetrix has a net margin of -203.71% compared to Envoy Medical's net margin of -7,607.55%. Envoy Medical's return on equity of 0.00% beat NeuroMetrix's return on equity.Company Net Margins Return on Equity Return on Assets Envoy Medical-7,607.55% N/A -262.28% NeuroMetrix -203.71%-42.56%-39.26% Which has better earnings and valuation, COCH or NURO? NeuroMetrix has higher revenue and earnings than Envoy Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnvoy Medical$320K91.76-$29.91MN/AN/ANeuroMetrix$5.90M1.41-$6.53M-$4.59-0.89 Which has more volatility and risk, COCH or NURO? Envoy Medical has a beta of 2.34, meaning that its stock price is 134% more volatile than the S&P 500. Comparatively, NeuroMetrix has a beta of 2.2, meaning that its stock price is 120% more volatile than the S&P 500. Does the MarketBeat Community prefer COCH or NURO? NeuroMetrix received 277 more outperform votes than Envoy Medical when rated by MarketBeat users. However, 100.00% of users gave Envoy Medical an outperform vote while only 57.96% of users gave NeuroMetrix an outperform vote. CompanyUnderperformOutperformEnvoy MedicalOutperform Votes7100.00% Underperform VotesNo VotesNeuroMetrixOutperform Votes28457.96% Underperform Votes20642.04% Do analysts recommend COCH or NURO? Envoy Medical presently has a consensus target price of $8.00, suggesting a potential upside of 451.72%. Given Envoy Medical's stronger consensus rating and higher possible upside, analysts plainly believe Envoy Medical is more favorable than NeuroMetrix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Envoy Medical 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00NeuroMetrix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryEnvoy Medical beats NeuroMetrix on 9 of the 16 factors compared between the two stocks. Get NeuroMetrix News Delivered to You Automatically Sign up to receive the latest news and ratings for NURO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NURO vs. The Competition Export to ExcelMetricNeuroMetrixSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.34M$4.83B$5.39B$9.14BDividend YieldN/A52.58%5.37%4.00%P/E Ratio-0.8926.1388.1017.53Price / Sales1.4161.291,285.4080.11Price / CashN/A50.8936.6032.90Price / Book0.317.894.954.67Net Income-$6.53M$13.87M$117.96M$224.69M7 Day Performance2.66%4.06%2.49%3.32%1 Month Performance4.77%11.17%3.44%5.36%1 Year Performance36.20%33.28%27.06%22.59% NeuroMetrix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NURONeuroMetrix0.4839 of 5 stars$4.06+0.2%N/A+35.0%$8.28M$5.90M-0.8820Positive NewsHigh Trading VolumeCOCHEnvoy Medical2.3491 of 5 stars$1.58+7.7%$8.00+405.4%+4.7%$32.04M$278,000.000.0034SURGSurgePays3.2768 of 5 stars$1.58-6.0%$8.50+438.0%-75.2%$31.86M$83.60M-1.4040News CoveragePositive NewsPOCIPrecision Optics0.5259 of 5 stars$4.88+1.7%N/A-19.6%$30.99M$18.98M-7.8780Positive NewsGap DownIRIXIRIDEX0.5682 of 5 stars$1.63-1.0%$2.00+22.5%-40.3%$27.17M$48.43M-2.44120Analyst ForecastNews CoveragePositive NewsDRIODarioHealth2.5378 of 5 stars$0.79-14.1%$4.00+406.1%-69.8%$26.95M$23.05M-0.84200News CoverageGap UpXAIRBeyond Air4.3191 of 5 stars$0.36-6.3%$3.67+911.2%-68.0%$26.18M$2.34M-0.2670News CoveragePTHLPheton Holdings Ltd Class A Ordinary SharesN/A$3.90-1.0%N/AN/A$25.67M$572,291.000.0011Positive NewsGap DownCODXCo-Diagnostics3.7248 of 5 stars$0.76-8.2%$1.50+96.9%-34.8%$24.33M$7.32M-0.55100BSGMBioSig Technologies1.5676 of 5 stars$1.41-2.1%$2.75+95.0%-56.9%$24.30M$39,000.000.0050FEMYFemasys3.3 of 5 stars$1.05-2.8%$10.00+852.4%+38.8%$24.04M$1.26M-1.3030Positive News Related Companies and Tools Related Companies Envoy Medical Competitors SurgePays Competitors Precision Optics Competitors IRIDEX Competitors DarioHealth Competitors Beyond Air Competitors Pheton Holdings Ltd Class A Ordinary Shares Competitors Co-Diagnostics Competitors BioSig Technologies Competitors Femasys Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NURO) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroMetrix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroMetrix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.